2 companies
argenx
Market Cap: €42.9b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€701.00
7D
4.1%
1Y
11.6%
Ion Beam Applications
Market Cap: €451.3m
Designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally.
IBAB
€15.42
7D
2.9%
1Y
13.0%